lifestyle.capitolhilltimes.com

Author: Precigen

New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis

January 23, 2026
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference

January 12, 2026
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 5, 2026
Precigen Reports Third Quarter 2025 Financial Results and Business Updates

November 18, 2025